跳至主要内容
临床试验/NCT00348764
NCT00348764已完成3 期

Treatment of Greater Saphenous Vein (GSV) Insufficiency Using Echo-Guided Sclerotherapy With Lauromacrogol 400 Foam -Comparative Study of 3% Versus 1% Concentration.

University Hospital, Grenoble2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2004年3月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
150
试验地点
2
主要终点
Removal of truncular GSV incompetence evaluated at 6 months by echo doppler: no persistence of "sus gonal" saphenous reflux > 1 second.

研究概览

简要总结

To evaluate the efficacy and the tolerance of echoguided sclerotherapy using Lauromacrogol 400 foam for the treatment of Great Saphenous Vein (GSV) insufficiency. A comparative study of 3% versus 1% Lauromacrogol 400 foam.

详细描述

A multicenter randomized double blind study to evaluate the efficacy and the tolerance of echoguided sclerotherapy using 3% versus 1% Lauromacrogol 400 foam in the treatment of Great Saphenous Vein (GSV) insufficiency.

One hundred fifty eligible patients will be recruited during 6 months from 9 study centers with a follow up period of 3 years and 7 visits at day 8, 6 weeks, 3 months, 6 months, 1,2 ,and 3 years.

After randomization, the patients will be treated by echoguided sclerotherapy with 1% or 3% Lauromacrogol 400 foam (ratio 1:1).

Monitoring is performed by doppler at 8 days, 6 weeks, 6 months , 1,2 ,and 3 years.

Effectiveness of sclerotherapy is determined at 6 weeks, 3 months and 6 months. A additional injection of 4 ml of foam can be performed if needed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
25 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 25 - 75 years
  • Hawaii CEAP classification : C2-5 Ep, As2-3 Pr
  • Clinical Varicose veins C2, Edema C3, Skin changes C4, Healed ulcer C5
  • Etiology Ep Primary GSV insufficiency
  • As2-3: Ostial and or crural truncular GVS incompetence
  • Maximal inferior diameter of the leg GSV (patient in decubitus) between 4 and 8mm
  • Pr: reflux by echo doppler in orthostatism > 1 second
  • Information consent form signed by the investigator and the patient.

排除标准

  • deep venous reflux (CEAP: Ad)
  • Short saphenous vein or non saphenous network insufficiency (CEAP: A4-5)
  • Clinical class: C1 or C6
  • Recurrent GSV varicose veins after stripping
  • Thrombophilia or antecedent of deep vein thrombosis
  • Psychiatric disorders
  • Known allergy to Lauromacrogol or to one of its component
  • Arteriopathy. (IPS < 0.8)
  • Post-thrombotic disease
  • Chronic hepatoma
  • Renal insufficiency (creatinine > 150 micromol/l)

结局指标

主要结局

Removal of truncular GSV incompetence evaluated at 6 months by echo doppler: no persistence of "sus gonal" saphenous reflux > 1 second.

次要结局

  • Removal of truncular GSV incompetence evaluated at 6 months by echo doppler: no persistence of "sus gonal" saphenous reflux > 1 second.

研究者

发起方
University Hospital, Grenoble
申办方类型
Other

研究点 (2)

Loading locations...

相似试验